Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1995 Jul;33(7):1765–1768. doi: 10.1128/jcm.33.7.1765-1768.1995

Detection and quantification of virus DNA in plasma of patients with Epstein-Barr virus-associated diseases.

M Yamamoto 1, H Kimura 1, T Hironaka 1, K Hirai 1, S Hasegawa 1, K Kuzushima 1, M Shibata 1, T Morishima 1
PMCID: PMC228265  PMID: 7665644

Abstract

Epstein-Barr virus (EBV) causes various diseases, such as infectious mononucleosis (IM), fatal IM, EBV-associated hemophagocytic syndrome (EBVAHS), and chronic active EBV infection (CAEBV). In the present study, cell-free EBV DNA was detected in the plasma of patients with EBV-associated diseases by PCR assay. The patients included 20 patients with IM, 2 patients with fatal IM, 4 patients with EBVAHS, 4 patients with CAEBV, and 38 healthy children (20 EBV seropositive and 18 EBV seronegative). In patients with IM, plasma samples were positive for EBV DNA in all patients (100%) in the acute phase and in 44% of the patients in the convalescent phase, but plasma samples from the 38 healthy control children were negative (0%) for EBV DNA. Quantitative PCR assay revealed that plasma from patients with IM contained the highest amount of virus DNA within 7 days following the onset of disease (mean, 6 x 10(4) copies per ml). The EBV DNA concentration decreased thereafter as the patients recovered. Plasma from patients with fatal IM contained more than 100 times more copies of EBV DNA (3 x 10(7) copies per ml) than plasma from patients with IM. Plasma from patients with the acute phase of EBVAHS contained 10 times more copies of EBV DNA (5 x 10(5) copies per ml) than plasma from IM, and then patients with the number of copies decreased similarly in both groups of patients in the convalescent phase (2 x 10(4) copies per ml). The amount of virus DNA in patients with CAEBV (6 x 10(4) copies per ml) was similar to that noted in patients with IM; however, it became higher (1 x 10(6) copies per ml) when the patients' clinical status deteriorated.(ABSTRACT TRUNCATED AT 250 WORDS)

Full Text

The Full Text of this article is available as a PDF (195.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ando Y., Kimura H., Miwata H., Kudo T., Shibata M., Morishima T. Quantitative analysis of herpes simplex virus DNA in cerebrospinal fluid of children with herpes simplex encephalitis. J Med Virol. 1993 Oct;41(2):170–173. doi: 10.1002/jmv.1890410214. [DOI] [PubMed] [Google Scholar]
  2. Brillanti S., Garson J. A., Tuke P. W., Ring C., Briggs M., Masci C., Miglioli M., Barbara L., Tedder R. S. Effect of alpha-interferon therapy on hepatitis C viraemia in community-acquired chronic non-A, non-B hepatitis: a quantitative polymerase chain reaction study. J Med Virol. 1991 Jun;34(2):136–141. doi: 10.1002/jmv.1890340213. [DOI] [PubMed] [Google Scholar]
  3. Edlin B. R., Weinstein R. A., Whaling S. M., Ou C. Y., Connolly P. J., Moore J. L., Bitran J. D. Zidovudine-interferon-alpha combination therapy in patients with advanced human immunodeficiency virus type 1 infection: biphasic response of p24 antigen and quantitative polymerase chain reaction. J Infect Dis. 1992 May;165(5):793–798. doi: 10.1093/infdis/165.5.793. [DOI] [PubMed] [Google Scholar]
  4. Fleisher G. R., Paradise J. E., Lennette E. T. Leukocyte response in childhood infectious mononucleosis. Caused by Epstein-Barr virus. Am J Dis Child. 1981 Aug;135(8):699–702. doi: 10.1001/archpedi.1981.02130320013004. [DOI] [PubMed] [Google Scholar]
  5. Gan Y. J., Sullivan J. L., Sixbey J. W. Detection of cell-free Epstein-Barr virus DNA in serum during acute infectious mononucleosis. J Infect Dis. 1994 Aug;170(2):436–439. doi: 10.1093/infdis/170.2.436. [DOI] [PubMed] [Google Scholar]
  6. Gerper P., Whang-Peng J., Monroe J. H. Transformation and chromosome changes induced by Epstein-Barr virus in normal human leukocyte cultures. Proc Natl Acad Sci U S A. 1969 Jul;63(3):740–747. doi: 10.1073/pnas.63.3.740. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gopal M. R., Thomson B. J., Fox J., Tedder R. S., Honess R. W. Detection by PCR of HHV-6 and EBV DNA in blood and oropharynx of healthy adults and HIV-seropositives. Lancet. 1990 Jun 30;335(8705):1598–1599. doi: 10.1016/0140-6736(90)91433-b. [DOI] [PubMed] [Google Scholar]
  8. Jones M. D., Griffin B. E. Clustered repeat sequences in the genome of Epstein Barr virus. Nucleic Acids Res. 1983 Jun 25;11(12):3919–3937. doi: 10.1093/nar/11.12.3919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kikuta H., Sakiyama Y., Matsumoto S., Oh-Ishi T., Nakano T., Nagashima T., Oka T., Hironaka T., Hirai K. Fatal Epstein-Barr virus-associated hemophagocytic syndrome. Blood. 1993 Dec 1;82(11):3259–3264. [PubMed] [Google Scholar]
  10. Kimura H., Ando Y., Shibata M., Abe T., Morishima T. T-cell receptor V alpha region usage in the cerebrospinal fluid of patients with mumps meningitis. J Med Virol. 1993 Dec;41(4):306–311. doi: 10.1002/jmv.1890410409. [DOI] [PubMed] [Google Scholar]
  11. Kwok S., Higuchi R. Avoiding false positives with PCR. Nature. 1989 May 18;339(6221):237–238. doi: 10.1038/339237a0. [DOI] [PubMed] [Google Scholar]
  12. Mahalingam R., Wellish M., Lederer D., Forghani B., Cohrs R., Gilden D. Quantitation of latent varicella-zoster virus DNA in human trigeminal ganglia by polymerase chain reaction. J Virol. 1993 Apr;67(4):2381–2384. doi: 10.1128/jvi.67.4.2381-2384.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mroczek E. C., Weisenburger D. D., Grierson H. L., Markin R., Purtilo D. T. Fatal infectious mononucleosis and virus-associated hemophagocytic syndrome. Arch Pathol Lab Med. 1987 Jun;111(6):530–535. [PubMed] [Google Scholar]
  14. Okano M., Matsumoto S., Osato T., Sakiyama Y., Thiele G. M., Purtilo D. T. Severe chronic active Epstein-Barr virus infection syndrome. Clin Microbiol Rev. 1991 Jan;4(1):129–135. doi: 10.1128/cmr.4.1.129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Purtilo D. T., Tatsumi E., Manolov G., Manolova Y., Harada S., Lipscomb H., Krueger G. Epstein-Barr virus as an etiological agent in the pathogenesis of lymphoproliferative and aproliferative diseases in immune deficient patients. Int Rev Exp Pathol. 1985;27:113–183. [PubMed] [Google Scholar]
  16. Riddler S. A., Breinig M. C., McKnight J. L. Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients. Blood. 1994 Aug 1;84(3):972–984. [PubMed] [Google Scholar]
  17. Risdall R. J., McKenna R. W., Nesbit M. E., Krivit W., Balfour H. H., Jr, Simmons R. L., Brunning R. D. Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer. 1979 Sep;44(3):993–1002. doi: 10.1002/1097-0142(197909)44:3<993::aid-cncr2820440329>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  18. Rocchi G., Felici A., Ragona G., Heinz A. Quantitative evaluation of Epstein-Barr-virus-infected mononuclear peripheral blood leukocytes in infectious mononucleosis. N Engl J Med. 1977 Jan 20;296(3):132–134. doi: 10.1056/NEJM197701202960302. [DOI] [PubMed] [Google Scholar]
  19. Semple M., Loveday C., Weller I., Tedder R. Direct measurement of viraemia in patients infected with HIV-1 and its relationship to disease progression and zidovudine therapy. J Med Virol. 1991 Sep;35(1):38–45. doi: 10.1002/jmv.1890350109. [DOI] [PubMed] [Google Scholar]
  20. Shibata M., Terashima M., Kimura H., Kuzushima K., Yoshida J., Horibe K., Morishima T. Quantitation of cytomegalovirus DNA in lung tissue of bone marrow transplant recipients. Hum Pathol. 1992 Aug;23(8):911–915. doi: 10.1016/0046-8177(92)90404-q. [DOI] [PubMed] [Google Scholar]
  21. Skare J., Strominger J. L. Cloning and mapping of BamHi endonuclease fragments of DNA from the transforming B95-8 strain of Epstein-Barr virus. Proc Natl Acad Sci U S A. 1980 Jul;77(7):3860–3864. doi: 10.1073/pnas.77.7.3860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Spector S. A., Merrill R., Wolf D., Dankner W. M. Detection of human cytomegalovirus in plasma of AIDS patients during acute visceral disease by DNA amplification. J Clin Microbiol. 1992 Sep;30(9):2359–2365. doi: 10.1128/jcm.30.9.2359-2365.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Sumaya C. V., Ench Y. Epstein-Barr virus infectious mononucleosis in children. I. Clinical and general laboratory findings. Pediatrics. 1985 Jun;75(6):1003–1010. [PubMed] [Google Scholar]
  24. Sumaya C. V., Ench Y. Epstein-Barr virus infectious mononucleosis in children. II. Heterophil antibody and viral-specific responses. Pediatrics. 1985 Jun;75(6):1011–1019. [PubMed] [Google Scholar]
  25. Telenti A., Marshall W. F., Smith T. F. Detection of Epstein-Barr virus by polymerase chain reaction. J Clin Microbiol. 1990 Oct;28(10):2187–2190. doi: 10.1128/jcm.28.10.2187-2190.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Wagner H. J., Bein G., Bitsch A., Kirchner H. Detection and quantification of latently infected B lymphocytes in Epstein-Barr virus-seropositive, healthy individuals by polymerase chain reaction. J Clin Microbiol. 1992 Nov;30(11):2826–2829. doi: 10.1128/jcm.30.11.2826-2829.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Yamaguchi Y., Hironaka T., Kajiwara M., Tateno E., Kita H., Hirai K. Increased sensitivity for detection of human cytomegalovirus in urine by removal of inhibitors for the polymerase chain reaction. J Virol Methods. 1992 May;37(2):209–218. doi: 10.1016/0166-0934(92)90048-i. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES